Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)

Location:

Rochester, Minn.

Trial status:

Open for Enrollment

Why is this study being done?

Study question: Do mutations within certain genes cause or confer susceptibility to spontaneous coronary artery dissection (SCAD)? Specific aims: 1. Create a genomic DNA and plasma biobank for individuals diagnosed with SCAD. 2. Identify inherited and de novo/new mutations that underlie SCAD. Long term objective:Discover molecular and cellular mechanisms of SCAD and develop biomarkers to enable prediction and prevention. The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person. The study includes individuals diagnosed with spontaneous coronary artery dissection and their biological parents. Adults with SCAD will be identified both retrospectively and prospectively.Confirmation of the diagnosis by review of coronary angiography will be required before proceeding with the informed consent process and blood sample procurement.

Who is eligible to participate?

Inclusion Criteria: - Men and women able to give informed consent and complete a 2 page questionnaire - Diagnosis of one or more episodes of spontaneous coronary artery dissection (SCAD) - Biological parent of individual with SCAD Exclusion Criteria: - Lack of confirmation of SCAD diagnosis

Last updated:

11/12/2014

NCT ID:

NCT01427179

IRB Number:

11-000160